The provision of OAMT presents unique challenges compared to other medications, particularly now during the current COVID-19 pandemic. Solutions to these challenges are a shared responsibility between the patient, their primary prescriber and pharmacists, and need to be made in consideration of the fine balance between the public health risk
The PEI College of Pharmacy has recently approved a policy for temporary closures due to COVID-19. If a pharmacy is unable to continue to operate due to COVID-19, the pharmacy may close temporarily. If a temporary closure is required, please notify the PEICP office as soon as possible via email.
Updated May 22, 2020 Pharmacy professionals in PEI are beginning to report improvements in the drug supply issues which triggered the decision to recommend 30-day supply limits in March 2020. Wholesalers have also indicated a stabilization in inventory allowing for more consistent fulfillment of pharmacy orders. Therefore, effective Friday May
In response to the evolving health risk posed by the COVID-19 pandemic, the Office of Controlled Substances (OCS) is taking temporary measures to reduce the likelihood of spreading COVID-19 between consumers and pharmacists when returning products that may contain controlled substances to a pharmacy. More information can be found in
Health Canada Exemption To maintain Canadians’ access to controlled substances for medical treatments (e.g., treatment of substance use disorders and chronic pain), while they adhere to social distancing guidance from public health officials or if they need to self-isolate, Health Canada has issued a temporary exemption under Section 56(1) of
The PEI College of Pharmacy has become aware of inappropriate prescribing of medications for the prevention and/or treatment of COVID-19 in jurisdictions in Canada and the USA. Prescriptions have included: hydroxychloroquine, azithromycin and antiretroviral medications. Inappropriate prescribing of these medications may lead to potential shortages and access for patients who
In response to the evolving health risk posed by the COVID-19 pandemic, the Office of Controlled Substances (OCS) is allowing temporary measures to reduce the likelihood of spreading COVID-19 between parties when taking delivery of narcotics, controlled drugs and restricted drugs while maintaining record keeping requirements. The following bulletin was